In line with the draft methods for developing quality standards, the development of the quality standard will be the responsibility of a separate group. This will include topics experts, some of whom will be drawn from the Guideline Development Group. The clinical guideline scope will form the basis from which the clinical guideline will be developed and the quality standard scope will inform the development of the quality standard, which will be developed following completion of the clinical guideline.
13 December 2011
Development of the clinical guideline is under way and is being led by the National Collaborating Centre. The Guideline Development Group meets regularly to oversee and assist the identification, review and synthesis of the evidence, the incorporation of expert consensus opinion and the translation of the evidence into recommendations for practice and audit criteria. Two versions of the guideline are under preparation: a full guideline and a NICE short-form guideline. Please see timescales above for dates of consultation with stakeholders.
14 June 2011
The draft scope is out for consultation with stakeholders. The scope defines what aspects of care the guideline will cover and to whom it will apply. If you wish to comment, you need to do so via one of the registered stakeholder organisations listed, by the deadline shown.
4 January 2011
The remit was received from the Department of Health and the Welsh Assembly Government in November 2010 as part of the Institute's 25th wave work programme.
NICE guidelines [CG166]
Ulcerative Colitis: guideline consultation table with responses